keyword
https://read.qxmd.com/read/38652814/immunologic-profiling-of-immune-related-cutaneous-adverse-events-with-checkpoint-inhibitors-reveals-polarized-actionable-pathways
#1
JOURNAL ARTICLE
Mario E Lacouture, Elena Goleva, Neil Shah, Veronica Rotemberg, Lukas Kraehenbuehl, Kwami F Ketosugbo, Taha Merghoub, Tara Maier, Alexander Bang, Stephanie Gu, Trina Salvador, Andrea P Moy, Taras Lyubchenko, Olivia Xiao, Clifton F Hall, Evgeny Berdyshev, James Crooks, Ryan Weight, Jeffrey A Kern, Donald Y M Leung
PURPOSE: Immune-related cutaneous adverse events (ircAEs) occur in ≥50% of patients treated with checkpoint inhibitors (CPI), but mechanisms are poorly understood. EXPERIMENTAL DESIGN: Phenotyping/biomarker analyses were conducted in 200 patients on CPIs (139 with ircAEs, 61 without, control) to characterize their clinical presentation and immunologic endotypes. Cytokines were evaluated in skin biopsies, skin tape strip (STS) extracts and plasma using real-time PCR and Meso Scale Discovery multiplex cytokine assays...
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38652761/tnf-%C3%AE-signals-through-itk-akt-mtor-to-drive-cd4-t-cell-metabolic-reprogramming-which-is-dysregulated-in-rheumatoid-arthritis
#2
JOURNAL ARTICLE
Emma L Bishop, Nancy Gudgeon, Taylor Fulton-Ward, Victoria Stavrou, Jennie Roberts, Adam Boufersaoui, Daniel A Tennant, Martin Hewison, Karim Raza, Sarah Dimeloe
Upon activation, T cells undergo metabolic reprogramming to meet the bioenergetic demands of clonal expansion and effector function. Because dysregulated T cell cytokine production and metabolic phenotypes coexist in chronic inflammatory disease, including rheumatoid arthritis (RA), we investigated whether inflammatory cytokines released by differentiating T cells amplified their metabolic changes. We found that tumor necrosis factor-α (TNF-α) released by human naïve CD4+ T cells upon activation stimulated the expression of a metabolic transcriptome and increased glycolysis, amino acid uptake, mitochondrial oxidation of glutamine, and mitochondrial biogenesis...
April 23, 2024: Science Signaling
https://read.qxmd.com/read/38652401/suberanilohydroxamic-acid-saha-a-hdac-inhibitor-suppresses-the-effect-of-treg-cells-by-targeting-the-c-myc-ccl1-pathway-in-glioma-stem-cells-and-improves-pd-l1-blockade-therapy
#3
JOURNAL ARTICLE
Ting Sun, Bin Liu, Lize Cai, Youxin Zhou, Wei Yang, Yanyan Li
PURPOSE: A strong immunosuppressive tumor microenvironment (TME) represents the major barrier responsible for the failure of current immunotherapy approaches in treating Glioblastoma Multiforme (GBM). Within the TME, the regulatory T cells (Tregs) exert immunosuppressive effects on CD8+ T cell - mediated anti-cancer immune killing. Consequently, targeting and inhibiting their immunosuppressive function emerges as an effective therapeutic strategy for GBM. The present study aimed to investigate the mechanisms and effects of Suberanilohydroxamic Acid (SAHA), a histone deacetylase inhibitor, on immunosuppressive Tregs...
April 23, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38652350/association-between-cytotoxic-t-lymphocyte-associated-antigen-4-ctla-4-locus-and-early-onset-anti-acetylcholine-receptor-positive-myasthenia-gravis-in-serbian-patients
#4
JOURNAL ARTICLE
Ivana Djordjevic, Nemanja Garai, Stojan Peric, Jelena Karanovic, Jovan Pesovic, Milos Brkusanin, Dragana Lavrnic, Slobodan Apostolski, Dusanka Savic-Pavicevic, Ivana Basta
Genome-wide association studies (GWAS) have provided strong evidence that early- and late-onset MG have different genetic backgrounds. Recent in silico analysis based on GWAS results revealed rs231735 and rs231770 variants within CTLA-4 locus as possible MG causative genetic factors. We aimed to explore the association of rs231735 and rs231770 with MG in a representative cohort of Serbian patients. We conducted an age-, sex-, and ethnicity-matched case-control study. Using TaqMan allele discrimination assays, the frequency of rs231735 and rs231770 genetic variants was examined in 447 AChR-MG patients and 447 matched controls...
April 23, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38652335/combination-of-sj%C3%A3-gren-s-syndrome-and-anti-ku-syndrome-complicated-by-the-development-of-mucosa-associated-lymphoid-tissue-lymphoma-case-review-and-systematic-review-of-the-literature
#5
REVIEW
Oksana Andreevna Golovina, Anna Vasilievna Torgashina, Vadim Romanovich Gorodetskiy, Evgenia Vladimirovna Sockol, Elena Georgievna Sagina
The frequency of antibodies to Ku varies in various autoimmune diseases. In 2019, Spielmann et al. identified two types of anti-Ku syndrome based on a hierarchical clustering analysis. Sjögren's syndrome occurs both in the first type of anti-Ku syndrome and in the second type. Despite the fact that increased tissue expression of Ku proteins was noted in lymphocytic cells with focal sialoadenitis of the minor salivary glands in patients with primary Sjogren's syndrome, only 49 cases of a combination of anti-Ku antibodies and manifestations of Sjogren's syndrome have been described in the literature...
April 23, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38652178/challenges-and-strategies-in-relation-to-effective-car-t-cell-immunotherapy-for-solid-tumors
#6
REVIEW
Guangxun Yuan, Mengke Ye, Yixi Zhang, Xun Zeng
Chimeric Antigen Receptor T cell (CAR-T) therapy has revolutionized cancer treatment, but its application to solid tumors is limited. CAR-T cells have poor incapability of entering, surviving, proliferating, and finally exerting function in the tumor microenvironment. This review summarizes the main strategies related to enhancing the infiltration, efficacy, antigen recognition, and production of CAR-T in solid tumors. Additional applications of CAR-γδ T and macrophages are also discussed. We believe CAR-T will be a milestone in treating solid tumors once these problems are solved...
April 23, 2024: Medical Oncology
https://read.qxmd.com/read/38652012/natural-killer-cell-subsets-and-their-functional-molecules-in-peripheral-blood-of-the-patients-with-breast-cancer
#7
JOURNAL ARTICLE
Reza Darvishvand, Somayeh Rezaeifard, Razie Kiani, Sedigheh Tahmasebi, Zahra Faghih, Nasrollah Erfani
BACKGROUND: Natural killer (NK) cells, CD3- lymphocytes, are critical players in cancer immune surveillance. This study aimed to assess two types of CD3- NK cell classifications (subsets), that is, convectional subsets (based on CD56 and CD16 expression) and new subsets (based on CD56, CD27, and CD11b expression), and their functional molecules in the peripheral blood of patients with breast cancer (BC) in comparison with healthy donors (HDs). METHODS: Thirty untreated females with BC and 20 age-matched healthy women were enrolled...
April 2024: Immunity, Inflammation and Disease
https://read.qxmd.com/read/38652006/association-between-serum-25-hydroxyvitamin-d-level-and-inflammatory-markers-in-hemodialysis-treated-patients
#8
JOURNAL ARTICLE
Chunlei Luo, Xueyan Bian, Lingling Bao, Qingqing Xu, Chunyang Ji
OBJECTIVE: To investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) level with novel inflammatory markers in hemodialysis-treated patients. METHODS: A total of 167 maintenance hemodialysis-treated patients were enrolled in this cross-sectional study. The patients were divided into vitamin D deficiency (a serum 25(OH)D level <20 ng/mL) and nondeficiency (a serum 25(OH)D level ≥20 ng/mL) groups. The neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and monocyte to lymphocyte ratio (MLR) were calculated by the complete blood cell count...
April 2024: Immunity, Inflammation and Disease
https://read.qxmd.com/read/38651852/vitiligo-as-a-first-sign-of-vogt-koyanagi-harada-disease
#9
JOURNAL ARTICLE
Marija Vukojević, Nenad Vukojevic, Ante Vuković, Borna Rupčić, Mislav Blažević, Ante Blažević
Vogt-Koyanagi-Harada (VKH) disease is a multisystem disorder characterized by bilateral granulomatous panuveitis resulting in serous retinal detachments, disk edema, and a sunset glow fundus development. Furthermore, it is associated with various extraocular findings, such as tinnitus, hearing loss, vertigo, poliosis, and vitiligo (1). VKH is considered to be an autoimmune disease mediated by T-cells targeting melanocyte antigen tyrosinase peptide (2). Moreover, VKH more often occurs in individuals with a genetic predisposition to the disease, including those of Asian and Hispanic heritage (3)...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651850/mycosis-fungoides-with-large-cell-transformation-cd30-and-b-cell-chronic-lymphocytic-leukemia
#10
JOURNAL ARTICLE
Mikela Petković, Ivana Ilić, Ružica Jurakić Tončić, Ivo Radman-Livaja, Romana Čeović
Mycosis fugnoides (MF) is an indolent cutaneous T-cell lymphoma (CTLC) and is the most common of all cutaneous lymphomas. An increased risk for developing a second primary malignancy in patients with CTCL has been described in several studies, with a range from 1.04 to 2.4 (1-4). Caucasian males are at higher risk for MF development. MF is often diagnosed at ages between 55 and 67 years, and second malignancy usually occurs 5 or 6 years after the diagnosis of MF was established (5). The most common second primary malignancies include non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), lung carcinoma, bladder carcinoma, and melanoma...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651407/factors-governing-b-cell-recognition-of-autoantigen-and-function-in-type-1-diabetes
#11
REVIEW
Lindsay E Bass, Rachel H Bonami
Islet autoantibodies predict type 1 diabetes (T1D) but can be transient in murine and human T1D and are not thought to be directly pathogenic. Rather, these autoantibodies signal B cell activity as antigen-presenting cells (APCs) that present islet autoantigen to diabetogenic T cells to promote T1D pathogenesis. Disrupting B cell APC function prevents T1D in mouse models and has shown promise in clinical trials. Autoantigen-specific B cells thus hold potential as sophisticated T1D biomarkers and therapeutic targets...
April 1, 2024: Antibodies
https://read.qxmd.com/read/38651368/tnfr1-absence-is-not-crucial-for-different-types-of-cell-reaction-to-tnf-a-study-of-the-tnfr1-knockout-cell-model
#12
JOURNAL ARTICLE
Alina A Alshevskaya, Julia A Lopatnikova, Julia V Zhukova, Olga Y Perik-Zavodskaia, Saleh Alrhmoun, Irina A Obleukhova, Anna K Matveeva, Darya A Savenkova, Ilnaz R Imatdinov, Dmitry V Yudkin, Sergey V Sennikov
BACKGROUND: One of the mechanisms regulating the biological activity of tumor necrosis factor (TNF) in cells is the co-expression of TNFR1/TNFR2 receptors. A model with a differential level of receptor expression is required to evaluate the contribution of these mechanisms. AIM: The development of a cellular model to compare the effects of TNF on cells depending on the presence of both receptors and TNFR2 alone. METHODS: TNFR1 absence modifications of ZR-75/1 and K-562 cell lines were obtained by TNFR1 knockout...
April 3, 2024: Epigenomes
https://read.qxmd.com/read/38651108/primary-cns-vasculitis-insights-into-clinical-neuropathological-and-neuroradiological-characteristics
#13
JOURNAL ARTICLE
Tahani Saker Sheikh, Ayal Rozenberg, Goni Merhav, Alla Shifrin, Polina Stein, Shahar Shelly
BACKGROUND AND OBJECTIVES: Primary CNS vasculitis (PCNSV) is a rare inflammatory disorder that affects the blood vessels of the central nervous system (CNS). We aimed to analyze the neurological presentations, clinical follow-up, and long-term outcomes of patients with primary central nervous system vasculitis. METHODS: We conducted a retrospective analysis of medical records to assess the neurological presentation, rate of remission, and functional status at the last follow-up in patients with primary central nervous system vasculitis seen in our center in the last 13 years (2010-2023)...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38651033/the-tumor-immune-microenvironment-is-associated-with-recurrence-in-early-stage-lung-adenocarcinoma
#14
JOURNAL ARTICLE
Hiroaki Kanemura, Toshihide Yokoyama, Ryu Nakajima, Atsushi Nakamura, Hiroaki Kuroda, Yoshitaka Kitamura, Hiroyasu Shoda, Nobuaki Mamesaya, Yoshihiro Miyata, Tatsuro Okamoto, Kyoichi Okishio, Masahide Oki, Yuichi Sakairi, Toyofumi Fengshi Chen-Yoshikawa, Tadashi Aoki, Tatsuo Ohira, Isao Matsumoto, Kiyonobu Ueno, Takuro Miyazaki, Haruhisa Matsuguma, Hideoki Yokouchi, Tomoyuki Otani, Akihiko Ito, Kazuko Sakai, Yasutaka Chiba, Kazuto Nishio, Nobuyuki Yamamoto, Isamu Okamoto, Kazuhiko Nakagawa, Masayuki Takeda
INTRODUCTION: Immune checkpoint inhibitors have recently been approved for the treatment of early-stage NSCLC in the perioperative setting on the basis of phase 3 trials. However, the characteristics of such patients who are susceptible to recurrence after adjuvant chemotherapy or who are likely to benefit from postoperative immunotherapy have remained unclear. METHODS: This biomarker study (WJOG12219LTR) was designed to evaluate cancer stem cell markers (CD44 and CD133), programmed death-ligand 1 (PD-L1) expression on tumor cells, CD8 expression on tumor-infiltrating lymphocytes, and tumor mutation burden in completely resected stage II to IIIA NSCLC with the use of archived DNA and tissue samples from the prospective WJOG4107 trial...
April 2024: JTO clinical and research reports
https://read.qxmd.com/read/38650951/peripheral-cd4-t-cells-correlate-with-response-and-survival-in-patients-with-advanced-non-small-cell-lung-cancer-receiving-chemo-immunotherapy
#15
JOURNAL ARTICLE
Xin Yang, Qiao Li, Tianyang Zeng
BACKGROUND: The aim of the present study was to explore the potential of peripheral immune cells in predicting the response and prognosis of patients with advanced non-small cell lung cancer (NSCLC) receiving anti-PD-1 immunotherapy and platinum-based chemotherapy. PARTICIPANTS AND METHODS: We utilized flow cytometry to examine the levels and dynamics of blood immune cells in 79 advanced NSCLC patients treated with the chemoimmunotherapy between December 2019 and January 2022...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650947/association-between-systemic-inflammatory-indicators-with-the-survival-of-chronic-kidney-disease-a-prospective-study-based-on-nhanes
#16
JOURNAL ARTICLE
Yuan Chen, Yanfang Nie, Jiaying Wu, Chunsheng Li, Lu Zheng, Bixiu Zhu, Yu Min, Tao Ling, Xiaozhu Liu
BACKGROUND: systemic inflammation disorders were observed in chronic kidney disease (CKD). Whether the systemic inflammatory indicators could be optimal predictors for the survival of CKD remains less studied. METHODS: In this study, participants were selected from the datasets of the National Health and Nutrition Examination Survey (NHANES) between 1999 to 2018 years. Four systemic inflammatory indicators were evaluated by the peripheral blood tests including systemic immune-inflammation index (SII, platelet*neutrophil/lymphocyte), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650932/card11-regulates-the-thymic-treg-development-in-an-nf-%C3%AE%C2%BAb-independent-manner
#17
JOURNAL ARTICLE
Yu Hu, Lingli Han, Wenwen Xu, Tianci Li, Qifan Zhao, Wei Lu, Jinqiao Sun, Ying Wang
INTRODUCTION: CARD11 is a lymphoid lineage-specific scaffold protein regulating the NF-κB activation downstream of the antigen receptor signal pathway. Defective CARD11 function results in abnormal development and differentiation of lymphocytes, especially thymic regulatory T cells (Treg). METHOD: In this study, we used patients' samples together with transgenic mouse models carrying pathogenic CARD11 mutations from patients to explore their effects on Treg development...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650864/association-analysis-of-dopaminergic-degeneration-and-the-neutrophil-to-lymphocyte-ratio-in-parkinson-s-disease
#18
JOURNAL ARTICLE
Fengjiao Zhang, Bin Chen, Wenhua Ren, Yayun Yan, Xiaoqi Zheng, Shuxian Jin, Ying Chang
INTRODUCTION: Peripheral inflammatory responses are suggested to play a major role in the pathophysiology of Parkinson's disease (PD). The neutrophil-to-lymphocyte ratio (NLR), a new recognized biomarker, can reflect peripheral inflammation in PD. However, the association between the NLR and dopaminergic degeneration in PD remains unclear. METHODS: In this retrospective study, 101 enrolled PD patients were categorized into early-stage and advanced-stage PD based on the Hoehn and Yahr (HY) scale...
2024: Frontiers in Aging Neuroscience
https://read.qxmd.com/read/38650858/exploring-the-immunological-landscape-of-osteomyelitis-through-mendelian-randomization-analysis
#19
JOURNAL ARTICLE
Kehan Long, Ao Gong, Dou Yu, Sumiao Dong, Zhendong Ying, Lei Zhang
BACKGROUND: Osteomyelitis is a severe bone marrow infection, whose pathogenesis is not yet fully understood. This study aims to explore the causal relationship between immune cell characteristics and osteomyelitis, hoping to provide new insights for the prevention and treatment of osteomyelitis. METHODS: Based on two independent samples, this study employed a two-sample Mendelian randomization (MR) analysis to assess the causal relationship between 731 immune cell characteristics (divided into seven groups) and osteomyelitis...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38650846/disulfiram-an-anti-alcoholic-drug-targets-macrophages-and-attenuates-acute-rejection-in-rat-lung-allografts
#20
JOURNAL ARTICLE
Nobuyuki Yoshiyasu, Rei Matsuki, Masaaki Sato, Hirokazu Urushiyama, Etsuko Toda, Yasuhiro Terasaki, Masaki Suzuki, Aya Shinozaki-Ushiku, Yuya Terashima, Jun Nakajima
Macrophages contribute to post-transplant lung rejection. Disulfiram (DSF), an anti-alcoholic drug, has an anti-inflammatory effect and regulates macrophage chemotactic activity. Here, we investigated DSF efficacy in suppressing acute rejection post-lung transplantation. Male Lewis rats (280-300 g) received orthotopic left lung transplants from Fisher 344 rats (minor histocompatibility antigen-mismatched transplantation). DSF (0.75 mg/h) monotherapy or co-solvent only (50% hydroxypropyl-β-cyclodextrin) as control was subcutaneously administered for 7 days (n = 10/group)...
2024: Transplant International
keyword
keyword
364
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.